Dementia strategy urged

Kondro, Wayne
February 2010
CMAJ: Canadian Medical Association Journal;2/23/2010 Supplement, Vol. 182, pE169
Academic Journal
The article presents research findings on the foreseen rise of Canadians with Alzheimer's disease and other forms of dementia in Canada. The study, conducted by risk management consultant RiskAnalytica, has determined an epidemic to hit Canadians as the 500,000 dementia-related cases in 2008 to leap to 1.125 million in 2038. In response, a national dementia plan to lessen the burden of dementia on Canadian society is provided.


Related Articles

  • The Many Faces of Dementia. Shagam, Janet Yagoda // Radiologic Technology;Nov/Dec2009, Vol. 81 Issue 2, p153 

    Dementia is a progressive and incurable condition that in one way or another affects nearly everyone. Examples of specific types of dementia include Alzheimer disease, vascular dementia, frontotemporal dementia and dementia with Lewy bodies. Age is the primary risk factor for dementia and the...

  • Nutritional risk among older Canadians. Ramage-Morin, Pamela L.; Garriguet, Didier // Health Reports;Mar2013, Vol. 24 Issue 3, p3 

    Background Nutritional risk screening is typically done in clinical settings to identify individuals at risk of malnourishment. This article presents the first population-level assessment of nutritional risk based on a large national sample representative of Canadian householders aged 65 or...

  • When Someone You Love Has ALZHEIMER'S DISEASE. Mueller, Michelle // Current Health 2;Dec2003, Vol. 30 Issue 4, p29 

    Focuses on Alzheimer's disease, a disorder that causes the gradual loss of brain cells. INSET: In Her Own Words.

  • Cortical Change in Alzheimer's Disease Detected with a Disease-specific Population-based Brain Atlas. Thompson, Paul M.; Woods, Roger P.; Zoumalan, Chris I.; Lindshield, Chris J.; Blanton, Rebecca E.; Moussai, Jacob; Holmes, Colin J.; Toga, Arthur W.; Mega, Michael S.; Cummings, Jeffrey L. // Cerebral Cortex;Jan2001, Vol. 11 Issue 1, p1 

    Presents information on a study on Alzheimer's disease (AD). Details on the population-based maps of cortical gray matter loss in AD; Use of computational strategy to compute gyral patterns; Hypothesis; Materials and methods; Results; Discussion.

  • Nutritional Management of Individuals with Alzheimer's Disease and Other Progressive Dementias. Morris, Judith; Volicer, Ladislav // Nutrition in Clinical Care;May/Jun2001, Vol. 4 Issue 3, p148 

    Abstract Alzheimer's disease (AD) causes a steady loss of memory and a decline in the ability to care for oneself. Weight loss is an insidious, yet common, problem that requires intervention and supervision during all stages of the disease. In spite of swallowing difficulties, natural feeding...

  • Alzheimer's Disease: When Free Radicals Run Amok. Butterfield, Allan // Drug Discovery & Development;Jan2003, Vol. 6 Issue 1, p12 

    Focuses on the molecular basis of the disorder Alzheimer's disease. Pathogenesis of Alzheimer's disease; Definition of potentially additional therapeutic targets.

  • Alzheimer's disease and senile dementia, 1885-1920: An... Holstein, Martha // Journal of Aging Studies;Spring97, Vol. 11 Issue 1, p1 

    Presents information on a study which examined the number of reported cases of Alzheimer's disease and senile dementia from the period 1886 through 1920. Indepth look at the symptoms of Alzheimer's disease; Discussion on senile dementia; Reference to other studies conducted on this issue.

  • Distinguishing vascular dementia from Alzheimer's disease. Lewis, Laurie // Patient Care;10/30/1999, Vol. 33 Issue 17, p71 

    Attempts to differentiate vascular dementia from Alzheimer's disease. Assessment of the degree of cognitive impairment; Analysis of disease progression; Evaluation of neuroimaging findings; Diagnostic criteria.

  • A Rationale for Curcuminoids for the Prevention or Treatment of Alzheimer's Disease. Cole, G.M.; Yang, F.; Lim, G.P.; Cummings, J.L.; Masterman, D.L.; Frautschy, S.A. // Current Medicinal Chemistry - Immunology, Endocrine & Metabolic ;Mar2003, Vol. 3 Issue 1, p15 

    Alzheimer's disease (AD) is believed to involve increased soluble but toxic beta amyloid (A�) peptide aggregates, leading to the accumulation of insoluble A� deposits, inflammation, oxidative damage, tau pathology and ultimately cognitive deficits. Blocking A� formation early...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics